CVS Health Corp.
(NYSE:CVS) stock fell Wednesday despite the company reporting second-quarter results that exceeded Wall Street expectations and raising its full-year adjusted earnings outlook.
According to Benzinga Pro, the stock may be seeing profit-taking after rallying nearly 60% since the end of the first quarter.
CVS reported adjusted earnings of $2.58 per share, topping the analyst consensus estimate of $1.85.
Revenue increased 7.3% year over year to $106.10 billion, exceeding the consensus estimate of $100.11 billion.
